AOCCN2017

Presentation information

Parallel Session

[PS13] Parallel Session 13: Neurogenetics 2

Fri. May 12, 2017 3:40 PM - 5:30 PM Room A (1F Argos A・B)

Chair: Yu-ichi Goto (National Center of Neurology and Psychiatry), Hsi Chang (Taipei Medical University Hospital)

[PS13-2A-3 ] Somatic Mutations in Focal Malformed Brain with Epilepsy

Hoon-Chul Kang (Division of Pediatric Neurology, Department of Pediatrics, Severance Children’s Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea)

Mutations occur during cell division in all somatic lineages. A key recent advance has been the increasing identification
of somatic mutations in brain. For example, somatic mutations in several genes (PIK3CA, AKT3, TSC1/2 and MTOR) cause focal malformation of the brain, a malformation called that is highly associated with epilepsy. In addition, perturbed neuronal functions derived from malformation are rarely restricted to a focal area; instead, they are often spread via the neuronal network to affect other connected areas. Although somatic diversity is an evident feature of the brain, the extent to which somatic mutations affect the neuronal structure and function and their contribution to neurological disorders associated with disrupted brain connectivity remain largely unexplored. Notably, recent reports indicate that brain somatic mutations can indeed play a critical role that leads to the structural and functional abnormalities of the brain observed in several neurodevelopmental disorders. Here, I review the extent and significance of brain somatic mutations and provide my perspective regarding these mutations as potential molecular lesions underlying relatively common conditions with disrupted brain connectivity. Moreover, I discuss emerging technical platforms that will facilitate the detection of low-frequency somatic mutations and validate the biological functions of the identified mutations in the context of brain connectivity.
Disclosure: “This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number : HI15C1601).”